Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Expression Patterns of VEGF and Flk-1 in Human Endometrium during the Menstrual Cycle

Authors
Tsung-Hsuan Lai 1
Nikos Vlahos 2
Ie-Ming Shih 3
Yulian Zhao 3
1 Institute of Systems Biology and Bioinformatics, National Central University, Jhongli City, Taoyuan County, Taiwan; Fu Jen Catholic University School of Medicine, New Taipei City, Taiwan; Department of Obstetrics and Gynecology, C
2 Second Department of Obstetrics and Gynecology, University of Athens Medical School, Aretaieion Hospital, Athens, Greece
3 Department of Gynecology and Obstetrics, School of Medicine, Johns Hopkins University, Baltimore, USA
Abstract
Background: The VEGF is essential in the process of tissue remodeling and angiogenesis. Limited data is available on the expression and regulation of VEGF and its receptors in the human endometrium. The aim of this study was evaluation of expression patterns of VEGF and Flk-1 in human endometrium during the menstrual cycle. Methods: Sixty paraffin-embedded blocks of endometrial tissues from the patients with normal menstrual cycles were obtained. Tissue samples were assembled into tissue microarray slides and classified by histological dating into five phases: the proliferative (n=14), peri-ovulatory (n=9), early-secretory (n=12), mid-secretory (n=11) and late-secretory (n=14) phases. Immunohistochemical staining was performed using VEGF or Flk-1 monoclonal antibodies. The intensity of immunostain-ing was evaluated by the semi-quantitative scoring method (HSCORE). Kruskal-Wallis one-way analysis of variance and Scheff’s post-hoc test were used for statistical analysis. A p-value of <0.05 was considered statistically significant. Results: VEGF and Flk-1 were expressed in the three components of the endometrium at various phases of the menstrual cycle. In the stroma, the expression of VEGF varied among the phases (p<0.05). The expression of Flk-1 in the luminal and glandular epithelium revealed stronger intensity of immunostaining as compared with the stroma at the different phases (p<0.05). The level of Flk-1 expression also showed significant differences among the phases in the glandular epithelium with greatest expression at late-secretory phase (p<0.05). Conclusion: Temporal and spatial distribution of VEGF and Flk-1 expression in the three components of human endometrium during menstrual cycle suggests the functional role of angiogenesis in the remodeling process of endometrial tissue.
Keywords
Endometrium
Flk
1
menstrual cycle
Tissue microarray
VEGF
  1. Demir R, Yaba A, Huppertz B. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and im-plantation. Acta Histochem. 2010;112 (3):203-14.
  2. Meduri G, Bausero P, Perrot-Applanat M. Expression of vascular endothelial growth factor receptors in the human en-dometrium: modulation during the menstrual cycle. Biol Reprod. 2000;62(2):439-47.
  3. Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout themenstrual cycle and in early pregnancy. Reproduction. 2002;123(3):379-87.
  4. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA. 1998;95(2):548-53.
  5. Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA. 1998;95(20):11709-14.
  6. Koolwijk P, Peters E, van der Vecht B, Hornig C, Weich HA, Alitalo K, et al. Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro. Angiogenesis. 2001;4(1):53-60.
  7. Charnock-Jones DS, Sharkey AM, Rajput-Wil-liams J, Burch D, Schofield JP, Fountain SA, et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regula-tion in endometrial carcinoma cell lines. Biol Reprod. 1993;48(5): 1120-8.
  8. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, et al. Ovarian steroid regulation of vascular endothe-lial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the path-ogenesis of endometriosis. J Clin Endocrinol Metab. 1996;81(8): 3112-8.
  9. Qian Dong, Zhu Cheng. Functions of VEGF in female reproductive system. Chinese Science Bulletin. 2003;48(3):217-22.doi: 10.1007/BF03183286
  10. Das SK, Chakraborty I, Wang J, Dey SK, Hoffman LH. Expression of vascular endothelial growth factor (VEGF) and VEGF-receptor messenger ribonucleic acids in the peri-implantation rabbit uterus. Biol Reprod. 1997;56(6):1390-9.
  11. Chakraborty I, Das SK, Dey SK. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation. J Endocrinol. 1995;147(2): 339-52.
  12. Evans PW, Wheeler T, Anthony FW, Osmond C. A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy. Hum Reprod. 1998;13(4):1057-62.
  13. Moller B, Rasmussen C, Lindblom B, Olovsson M. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod. 2001;7(1):65-72.
  14. Gargett CE, Rogers PA. Human endometrial angi-ogenesis. Reproduction. 2001;121(2):181-6.
  15. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122(2): 262-3.
  16. Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, et al. Assessment of interlaboratory variation in the immunohistochem-ical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol. 2002;117(5):723-8.
  17. Okada H, Tsuzuki T, Shindoh H, Nishigaki A, Yasuda K, Kanzaki H. Regulation of decidualization and angiogenesis in the human endometrium: mini review. J Obstet Gynaecol Res. 2014;40(5):1180-7.
  18. Torry DS, Holt VJ, Keenan JA, Harris G, Caudle MR, Torry RJ. Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril. 1996;66(1):72-80.
  19. Naresh B, Sengupta J, Bhargava V, Kinra G, Hu J, Ghosh D. Immunohistological localisation of vascular endothelial growth factor in human endometrium. Indian J Physiol Pharmacol. 1999;43(2): 165-70.
  20. Fan X, Krieg S, Kuo CJ, Wiegand SJ, Rabinovitch M, Druzin ML, et al. VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J. 2008;22(10):3571-80.
  21. Hyder SM, Stancel GM. Regulation of VEGF in the reproductive tract by sex-steroid hormones. Histol Histopathol. 2000;15(1):325-34.
  22. Herve MA, Meduri G, Petit FG, Domet TS, Laze-nnec G, Mourah S, et al. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus. J Endocrinol. 2006;188(1):91-9.
  23. Okada H, Okamoto R, Tsuzuki T, Tsuji S, Yasuda K, Kanzaki H. Progestins inhibit estradiol-induced vascular endothe-lial growth factor and stromal cell-derived factor 1 in human endometrial stromal cells. Fertil Steril. 2011;96(3):786-91.
Journal of Reproduction & Infertility
Volume 16, Issue 1
Winter 2015
Pages 3-9